Chinese english Japanese Germany Korea
ChemicalBook > Product Catalog >Biochemical Engineering >nucleic acid drugs >PD 117519

PD 117519

PD 117519 Structure
CAS No.
96392-15-3
Chemical Name:
PD 117519
Synonyms
CI 947;PD 11751;PD 117519;PD 117519,R;PD 117519 (CI947);N-[(R)-Indan-1-yl]adenosine;N-[(1R)-Indan-1-yl]adenosine;(R)-N-(2,3-Dihydro-1H-indenyl)adenosine;PD-117519;PD 117519;PD117519;CI 947;CI947;N-[(1R)-2,3-Dihydro-1H-inden-1-yl]adenosine
CBNumber:
CB31872452
Molecular Formula:
C19H21N5O4
Molecular Weight:
383.4
MOL File:
96392-15-3.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:05
Request For Quotation

PD 117519 Properties

storage temp. 2-8°C
solubility DMF: 10mg/mL; DMF:PBS (pH 7.2) (1:4): 0.2mg/mL; DMSO: 5mg/mL; Ethanol: 0.1mg/mL
form A solid
color White to off-white
InChIKey FSKMJUWPFLDDRS-BYMDKACISA-N
SMILES OC[C@H]1O[C@@H](N2C3C(=C(N=CN=3)N[C@H]3C4=C(C=CC=C4)CC3)N=C2)[C@H](O)[C@@H]1O

PD 117519 Chemical Properties,Uses,Production

Uses

N6-Substituted adenosine receptor agonist; a potential antihypertensive agent.

in vitro

PD 117519 (2-10 mg/kg; oral administration; 16-24 hours; male beagle dogs) treatment produces significant hemodynamic changes at Tmax (4 hours) follows by acute coronary vascular injury that is evident at 16 hours postdosing.Treatment with 2 or 10 mg/kg of PD 117519 produces significant increases in mean heart rate and decreases in mean indirectsystolic blood pressure at time of highest drug exposure, 4 hours postdosing.

PD 117519 Preparation Products And Raw materials

Raw materials

Preparation Products

PD 117519 Suppliers

Global( 56)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD 0371-55159968 18137130222 China 466 58 Inquiry
Shenzhen Nexconn Pharmatechs Ltd +86-755-89396905 +86-15013857715 China 10318 58 Inquiry
SHANGHAI T&W PHARMACEUTICAL CO., LTD. +86-021-61551413 +8618813727289 China 5738 58 Inquiry
Career Henan Chemica Co +86-0371-86658258 +8613203830695 China 30253 58 Inquiry
BOC Sciences 16314854226; +16314854226 United States 19743 58 Inquiry
NewCan Biotech Limited +86-0571-86912261 +8613735419629 China 9980 58 Inquiry
LEAP CHEM CO., LTD. +86-852-30606658 China 24738 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 United States 19973 58 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 57511 58 Inquiry
Supplier Advantage
CLEARSYNTH LABS LTD. 58
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD 58
Shenzhen Nexconn Pharmatechs Ltd 58
SHANGHAI T&W PHARMACEUTICAL CO., LTD. 58
Career Henan Chemica Co 58
BOC Sciences 58
NewCan Biotech Limited 58
LEAP CHEM CO., LTD. 58
TargetMol Chemicals Inc. 58
Aladdin Scientific 58

PD 117519 Spectrum

PD 117519(96392-15-3)1HNMR
(R)-N-(2,3-Dihydro-1H-indenyl)adenosine N-[(1R)-Indan-1-yl]adenosine N-[[(R)-2,3-Dihydro-1H-inden]-1α-yl]adenosine CI 947 N-[(1R)-2,3-Dihydro-1H-inden-1-yl]adenosine PD 117519 N-[(R)-Indan-1-yl]adenosine Adenosine, N-[(1R)-2,3-dihydro-1H-inden-1-yl]- PD 117519,R PD 11751 PD-117519;PD 117519;PD117519;CI 947;CI947 N-[(R)-Indan-1-yl] adenosine, Drug, N-substituted adenosine receptor agonist, a potential antihypertensive agent N-[(R)-Indan-1-yl]adenosine, PD-117519, CI947 CI-947,PD-117519,Adenosine Receptor,Inhibitor,P1 receptor,PD117519,PD 117519,inhibit,CI 947 PD 117519 (CI947) 96392-15-3 Bases & Related Reagents Carbohydrates & Derivatives Intermediates & Fine Chemicals Nucleotides Pharmaceuticals